Pharmaceutical Robot Market
Pharmaceutical Robot Market Analysis By Type (Traditional Robots, Collaborative Robots), By Application (Picking & Packaging, Drugs Inspection, Laboratories), & By Region – Global Market Report 2023 to 2033
Analysis of Pharmaceutical Robot Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Pharmaceutical Robot Market Outlook (2023 to 2033)
According to a detailed research report by Fact.MR, the global pharmaceutical robot market size was valued at US$ 211 Million in 2022. Over the assessment period (2023 to 2033), the market is forecasted to advance at a CAGR of 6.7% and reach a valuation of US$ 431 Million by 2033-end.
Shortage of laborers in the pharmaceutical sector for intricate and repetitive tasks is predicted to boost worldwide demand for robots. They are projected to fill the gap while performing precise and monotonous tasks consistently and reducing dependency on human beings while ensuring effective production.
Prominent Market Growth Drivers
- Growing demand for pharmaceutical robots is attributed to their unparalleled accuracy and precision in tasks, including drug packaging, compounding, and dispensing owing to the ability to handle different delicate procedures that too with minimal effort.
- Ongoing advancements in machine learning, artificial intelligence, and robotics technology are leading to the development of more capable and smarter robots.
The Industrial Revolution 4 led to the widespread adoption of automation across different industries, including the pharmaceutical sector. Furthermore, rising need for higher accuracy and precision in medicine manufacturing is estimated to become one of the contributing reasons for the increased demand for pharmaceutical robots.
- Demand for traditional robots is predicted to increase at a CAGR of 5% and reach a market value of US$ 201.6 million by 2033.
- Sales of pharmaceutical robots in China are projected to expand at 6.2% CAGR and reach US$ 60.8 million by the end of 2033.
Several issues associated with drug development, including mistake reduction and cost savings, are projected to help in the application of robots in the manufacturing of pharmaceuticals. Different robot-enabled solutions help cut down expenditures with assured quality, which is further contributing to increased sales of robots in this industry. Governments from different countries are emphasizing the deployment of pharma robots in various publicly funded pharmaceutical organizations, which is further strengthening the position of players.
|Pharmaceutical Robot Market Size (2022A)||US$ 211 Million|
|Estimated Market Value (2023E)||US$ 225.2 Million|
|Forecasted Market Value (2033F)||US$ 431 Million|
|Global Market Growth Rate (2023 to 2033)||6.7% CAGR|
|United States Market Value (2022)||US$ 61.5 Million|
|Demand Projection for Traditional Robots (2033)||US$ 201.6 Million|
|Japan Market Growth Rate (2023 to 2033)||5.5% CAGR|
|Germany Market Growth Rate (2023 to 2033)||4.7% CAGR|
|Key Companies Profiled||
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Why are Pharmaceutical Robots Gaining Immense Popularity across the World?
“Rising Geriatric Population and Growing Prevalence of Chronic Diseases”
Escalating demand for medicines is generating the need for enhanced productivity, precision, and efficiency in pharmaceutical manufacturing procedures. In addition, the rising geriatric population and growing prevalence of chronic diseases necessitate a continuous supply of multiple pharmaceutical treatments, which is in turn generating demand for pharmaceutical robots for process optimization.
Advancements in the medical sector are predicted to enhance the range of different treatment conditions, leading to the development of various pharmaceutical products ranging from personalized medicines to some complex biopharmaceuticals. Moreover, robotics technology is emerging as a solution that can execute intricate tasks with unparalleled speed and accuracy, ensuring the effective production of different medicines.
“Pharmaceutical Automation Boosting Productivity and Accelerating Production Timelines”
Robotic technology is projected to transform the pharmaceutical sector while addressing several challenges. Moreover, the rising need for increased consistency and accuracy in multiple tasks, including drug dispensing, compounding, and formulation is forecasted to positively influence opportunities for players.
Robots with advanced programming and sensors can perform tasks in the pharmaceutical sector with minimal human errors, ensuring patient safety and product quality. Integration of robotics in the pharmaceutical sector is anticipated to optimize resources and accelerate production timelines to streamline operations. Pharmacy automation helps achieve increased productivity levels.
Incorporation of pharmaceutical automated systems helps in maintaining controlled and sterile environments and also minimizes the risks of cross-contamination.
Which Factors are Restraining the Demand Growth for Pharmaceutical Robots to Some Extent?
“Challenges Related to Integration of Pharmaceutical Robots with Existing Systems”
Integration of advanced pharmaceutical robots into current systems and production lines creates time-consuming and complex challenges. Process synchronization, software integration, and compatibility issues are predicted to pose hurdles during implementation. They cause delays in the adoption of advanced robotic solutions.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What Initiatives are Start-ups Taking to Stand Out in the Market?
“Investments in Development of Robots Designed for Tailored Pharmaceutical Services”
In recent years, there has been a significant increase in the need for personalized medicines. Robotic systems are used for the packaging of medications with customized doses. Start-ups need to invest in the development of pharmaceutical robots that can assist in tailored pharmaceutical services.
Asia Pacific held 70% of the global pharmaceutical robot market share in 2022 owing to the presence of many local pharmaceutical companies in regional markets, including Japan. Further, North America is also predicted to create noteworthy revenue streams because of increasing robot installations in the region’s pharmaceutical industry.
What is Contributing to Increased Demand for Pharmaceutical Robots in the United States?
“Market Benefitting from Wide Availability of AI Expertise”
Sales of pharmaceutical robots in the United States reached US$ 61.5 million in 2022. This growth is attributed to advancements taking place in technology along with the availability of various artificial intelligence experts and skilled engineers. In addition, rising investments in R&D activities for product advancements are also driving opportunities for players.
What Opportunities Do China and Japan Present for Pharmaceutical Robot Suppliers?
“Increasing Deployment of Pharmaceutical Robots Leading to Cost Benefits”
Sales of pharmaceutical robots in China are predicted to increase at a CAGR of 6.2% and reach a valuation of US$ 60.8 million by 2033-end. Furthermore, the Japanese market is forecasted to advance at a 5.5% CAGR from 2023 to 2033.
Increasing need for automation in the pharmaceutical industry is contributing to the sales of robots. Moreover, the deployment of pharmaceutical robots is predicted to minimize the chances of errors occurring because of human intervention. Deployment of pharmacy automation is anticipated to result in immediate price reduction in human labor and reduced cost of manufacturing. Presence of several prominent pharmaceutical companies with large production facilities in China and Japan is projected to contribute to global pharmaceutical robot market expansion.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Demand for pharmaceutical robots for picking & packaging applications accounted for 55.1% share of the revenue stream in 2022 due to their efficiency and high precision. Sales of traditional robots held a 65.1% share of market revenue in 2022 because of their deployment for multiple applications, including sorting, cutting, and stacking.
What Makes Traditional Robots a Popular Choice among End Users?
“Adoption of Pharmaceutical Robots as Pocket-friendly Service Compared to Collaborative Robots”
Worldwide sales of traditional robots are projected to advance at a CAGR of 5% and reach a value of US$ 201.6 million by 2033, as per a study published by Fact.MR, a market research and competitive intelligence provider. Rising adoption of traditional robots in inspection, picking & packing, material handling, etc., is projected to contribute to revenue streams. These robots held 65.1% share of the global market revenue in 2022.
Authentication, cleanliness, and high precision are some key standards of the pharmaceutical sector that are prompting the adoption of traditional robots. Moreover, they are accepted as economical solutions compared to collaborative robots.
Which Application of Pharmaceutical Robots Holds a Dominant Market Share?
“Efficient Tracking and Fast Speed of Pharmaceutical Robots Fueling Their Demand for Picking & Packaging”
Based on application, a significant share of the demand for pharmaceutical robots is projected to come from the picking & packaging industry. In 2022, demand for pharmaceutical robot systems in picking & packaging held a 55% share of the global market revenue.
Growing sales of pharmaceutical robots can be attributed to the rising demand for customized packaging and its associated benefits, such as optimal floor space utilization, efficient tracking, and high speed. Traditional robotic technologies are predominantly employed for picking and packaging purposes. The four-axis SCARA robot is one recent innovation from the picking & packaging segment. The higher accuracy and speed of robots are leading to their increased application in pick-and-place services.
Manufacturers of pharmaceutical robots are incorporating strategies to acquire a competitive edge, including new developments, ensuring quality control of products, management of supply chain systems, etc. Pharmaceutical robot market players are developing more advanced analytical products to extend offerings. They are also concentrating on product launches, technology collaborations, alliances, etc.
- Jianjia Robots, in September 2021, raised a significant amount to complete clinical registration for the development of joint replacement surgical robots of the company.
- ABB, in February 2021, introduced two new additions to its robot line. The firm is predicted to depend on collaborative robots for automation in the pharmaceutical industry.
ABB Ltd., Denso Wave Inc., Universal Robots A/S, Denso Corporation, Epson India Pvt. Ltd., Kawasaki Heavy Industries Ltd., FANUC Corporation, Mitsubishi Electric Corporation, Marchesini Group S.p.A., Seiko Epson Corporation, Transcriptic Inc., Shibuya Corporation, Yaskawa Electric Corporation, and KUKA AG are top players in the pharmaceutical robot market.
Segmentation of Pharmaceutical Robot Market Research
By Type :
- Traditional Robots
- Collaborative Robots
By Application :
- Picking & Packaging
- Drugs Inspection
By Region :
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
- FAQs -
The global pharmaceutical robot market reached US$ 211 million in 2022.
Sales of pharmaceutical robots in the United States were pegged at US$ 61.5 million in 2022.
The market for pharmaceutical robots is estimated at US$ 225.2 million in 2023.
Worldwide sales of pharmaceutical robots are predicted to rise at a CAGR of 6.7% through 2033.
The market is forecasted to reach US$ 431 million by the end of 2033.
Demand for traditional robots is projected to increase at a CAGR of 5% through 2033.
Robots play a pivotal role in discovering and manufacturing different types of drugs and health products with increased sustainability.